Surprisingly, humans with loss-of-function mutations in the CASP8 gene develop VEO-IBD that is refractory to TNF treatment [206], suggesting that ZBP1 (or possibly TLR signalling) may also drive intestinal inflammation in human patients. Here, CASP8 is linked to inflammatory bowel disease.